Cost per lead became the default metric in personal injury marketing for one reason: it is easy to measure. A vendor sends you 200 leads. You paid $10,000. Your cost per lead is $50. Done. Clean. Reportable.
That simplicity is exactly why every vendor in the industry loves reporting it. CPL is the metric that makes their performance look best, because it measures the one thing they control — generating initial contact — and ignores everything that happens after.
For two decades, PI firms have built their entire marketing evaluation framework around this number. Vendor reviews center on it. Budget conversations reference it. Performance dashboards highlight it. And most firms have never stopped to ask a simple question: is this actually the right metric to optimize for?
It is not. And the firms that figure this out first will have a structural advantage over every competitor still chasing cheap leads.
What CPL Actually Incentivizes
Every metric creates a set of incentives. The behaviors that improve the number are the behaviors that get repeated. When you optimize for cost per lead, here is what you are actually optimizing for:
- Volume over quality. The fastest way to lower CPL is to generate more leads from broader, less targeted audiences. Wider geographic targeting. Looser qualification criteria. More aggressive ad copy that pulls in anyone with a pulse and a phone number.
- Speed over qualification.Low-friction funnels — single-field forms, instant click-to-call — produce the cheapest leads. They also produce the least qualified ones. A lead who fills out a detailed intake form is more expensive to acquire and far more likely to become a signed case.
- Front-of-funnel activity over downstream outcomes. CPL rewards vendors for what happens before your intake team picks up the phone. It tells you nothing about what happens after.
None of these incentives are aligned with what your firm actually needs: signed cases that settle for meaningful amounts.
This is not a flaw in how CPL is calculated. It is a flaw in what CPL measures. The metric is doing exactly what it was designed to do. The problem is that what it was designed to do has almost nothing to do with your firm's revenue.
The Vendor Dynamic Nobody Talks About
Here is something that should concern every marketing director in PI: your vendors are experts at optimizing CPL. They have spent years — in some cases, decades — refining their ability to generate leads at the lowest possible cost per contact. They are very good at it.
The question is whether their expertise is aligned with your interests.
A vendor who optimizes for CPL will always win a CPL comparison. They will show you a lower number than last quarter. They will benchmark favorably against industry averages. Their reports will look great.
But here is what those reports will never show you: how many of those cheap leads turned into signed cases. What those cases were worth at settlement. Whether the $35 leads outperformed the $85 leads when you follow the money all the way to resolution.
This is not because vendors are dishonest. Most are not. It is because they do not have that data. They do not know what happens after the lead enters your intake pipeline. They cannot track it. And even if they could, their economic incentive would be to keep the conversation focused on the metric where they perform best.
When you evaluate vendors on CPL, you are evaluating them on their home turf, using their preferred scoreboard, measuring the one dimension of performance they have total control over. Of course they look good.
Two Scenarios That Expose the Illusion
Let these numbers settle in. They are composites drawn from real PI marketing data, and they illustrate a pattern that plays out at firms across the country every month.
Scenario One: The “Cheap” Vendor
Vendor A charges $15,000 per month and delivers 375 leads. That is a $40 CPL. Impressive. Your spreadsheet highlights it in green.
But only 8 of those 375 leads become signed cases. Your cost per signed case from Vendor A is $1,875. And when those 8 cases settle 12 to 18 months later, the average settlement is $45,000. Your firm's contingency fee on $45,000 is roughly $15,000. You spent $1,875 to acquire a case worth $15,000 in fees. That is an 8:1 return.
Not bad. But let us look at Vendor B.
Scenario Two: The “Expensive” Vendor
Vendor B charges $15,000 per month and delivers 150 leads. That is a $100 CPL. Your spreadsheet highlights it in red. In a CPL-driven review, this vendor is on the chopping block.
But 12 of those 150 leads become signed cases. Your cost per signed case from Vendor B is $1,250. And when those 12 cases settle, the average settlement is $85,000. Your contingency fee is roughly $28,300 per case. You spent $1,250 to acquire a case worth $28,300 in fees. That is a 22:1 return.
The vendor with the higher CPL produced more cases, better cases, and nearly three times the return on the same spend.
If you are making budget decisions on CPL alone, you would cut Vendor B and double down on Vendor A. You would move money away from a 22:1 return toward an 8:1 return. And your CPL report would tell you it was the right call.
This is not a hypothetical edge case. This pattern is the norm. The vendors generating the cheapest leads are rarely the ones generating the best cases. And firms that cannot see past CPL will never know the difference.
| Metric | Vendor A ($40 CPL) | Vendor B ($100 CPL) | |
|---|---|---|---|
| Monthly Spend | $15,000 | $15,000 | |
| Leads Delivered | 375 | 150 | |
| Signed Cases | 8 | 12 | |
| Cost Per Case | $1,875 | $1,250 | |
| Avg Settlement | $45,000 | $85,000 | |
| Fee Per Case | $15,000 | $28,300 | |
| Return on Spend | 8:1 | 22:1 |
When CPL Still Has Value
A manifesto that refuses to acknowledge nuance loses credibility. So let us be honest: cost per lead is not useless. It has a role. That role is just much smaller than most firms have assigned it.
CPL is useful in two specific situations:
- Early-stage vendor testing. When you first engage a new lead source, you do not yet have enough data to calculate cost per case. Settlements are 6 to 18 months away. In the first 30 to 60 days, CPL is a reasonable directional indicator. If a vendor is charging $200 per lead with no clear justification, that is worth flagging early. But the moment you have 90 days of intake data, CPL should step aside.
- Anomaly detection.If a vendor's CPL spikes 40% in a single month, that is a signal worth investigating. Not because CPL is the right decision metric, but because a sudden change in any input metric suggests something has shifted — audience targeting, ad creative, market conditions. CPL works as a canary in the coal mine. It does not work as the compass.
Outside of these two situations, CPL should not drive budget decisions. Period. It should appear on your dashboard as context, not as a headline.
What Replaces CPL as the Decision Metric
The metric that should sit at the center of every vendor review, every budget conversation, and every performance dashboard is cost per case.
Not because it is trendy. Not because it is new. Because it is the only metric that answers the question your managing partner is actually asking: how much does it cost us to acquire a case that generates revenue?
Cost per case connects spend to outcomes. It forces accountability through the entire funnel — from initial contact through intake qualification through case signing. It makes vendor performance transparent in a way that CPL never can.
And when you extend it further — connecting cost per case to average settlement value by source — you get the full picture. You can calculate your actual return on every dollar spent with every vendor. Not estimated. Not projected. Actual.
Go deeper: Read our definitive guide to cost per case for the formulas, benchmarks by firm size, and step-by-step methodology for tracking this metric across every vendor in your portfolio.
This is a philosophical shift, not a tactical one. It is not about adding a column to your spreadsheet. It is about changing what you believe matters. CPL asks: how cheaply can we fill the top of the funnel? Cost per case asks: how efficiently can we acquire revenue?
Those are fundamentally different questions. And they lead to fundamentally different decisions.
15-20%
marketing ROI improvement within 90 days for firms that switch from CPL to cost-per-case tracking
The Industry Shift That Is Already Happening
The personal injury firms that will outperform over the next five years are not the ones spending the most on marketing. They are the ones who know exactly what their marketing produces.
Right now, more than 80% of PI firms still track marketing performance manually — in spreadsheets, in vendor-provided reports, or not at all. Most of them are making six- and seven-figure annual budget decisions based on CPL, gut instinct, and vendor promises.
That is starting to change. The firms that have moved to cost-per-case tracking are seeing 15 to 20% improvements in marketing ROI within 90 days. Not because they found better vendors. Because they finally had the data to tell which vendors were already better — and reallocated accordingly.
The gap between firms that measure and firms that guess is going to widen. It has to. When one firm in a market knows that Vendor C produces cases at $1,100 each with an average settlement of $90,000, and the firm across town is still comparing $45 CPL versus $60 CPL, the first firm will make better decisions every single month. Over years, that compounds.
CPL is not going to disappear from vendor reports. Vendors will keep reporting it because it serves their interests. The question is whether you will keep letting it drive yours.
Cost per lead is not a bad metric. It is the wrong metric. It measures what is easiest to count, not what matters most to count. And the difference between those two things is where most PI marketing budgets go to waste.
The firms that recognize this — that stop optimizing for cheap leads and start optimizing for efficient case acquisition — will not just save money. They will prove it. To their partners, to their teams, and to themselves.
That is the case against cost per lead. Not that it is worthless. But that it has been given a job it was never qualified to do.
